|
|
||||||||
From the Johns Hopkins School of Public Health, Baltimore, MD and Innovative Medical Research, Inc., Hunt Valley, MD (Dr. Stewart); the Albert Einstein College of Medicine, Bronx, NY and Innovative Medical Research, Inc., Stamford, CT (Dr. Lipton); the Kings Headache Service, Kings College Hospital, London, UK (Dr. Dowson); and Willaston, Cheshire, UK (Dr. Sawyer).
Address correspondence and reprint requests to Dr. Walter Stewart, Innovative Medical Research, Inc., 1200 High Ridge Road, Stamford, CT 06905. e-mail: bstewart{at}imrinc.com
The MIDAS Questionnaire was developed to assess headache-related disability with the aim of improving migraine care. Headache sufferers answer five questions, scoring the number of days, in the past 3 months, of activity limitations due to migraine. The internal consistency, testretest reliability, and validity (accuracy) of the questionnaire were assessed in separate population-based studies of migraine sufferers. In addition, the face validity, ease of use, and clinical utility of the questionnaire were evaluated in a group of 49 physicians who independently rated disease severity and need for care in a diverse sample of migraine case histories. The testretest Pearson correlation coefficient for the total MIDAS score was approximately 0.8. The MIDAS score was valid when compared with a reference diary-based measure of disability; the overall correlation between MIDAS and the diary-based measure was 0.63. The MIDAS score was also correlated with physicians assessments of need for medical care (r = 0.69). From studies completed to date, the MIDAS Questionnaire has been shown to be internally consistent, highly reliable, valid, and correlates with physicians clinical judgment. These features support its suitability for use in clinical practice. Use of the MIDAS Questionnaire may improve physicianpatient communication about headache-related disability and may favorably influence health-care delivery for migraine patients.
This article has been cited by other articles:
![]() |
A. Dowson, M. J. Mullen, R. Peatfield, K. Muir, A. A. Khan, C. Wells, S. L. Lipscombe, T. Rees, J. V. De Giovanni, W. L. Morrison, et al. Migraine Intervention With STARFlex Technology (MIST) Trial: A Prospective, Multicenter, Double-Blind, Sham-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With STARFlex Septal Repair Implant to Resolve Refractory Migraine Headache Circulation, March 18, 2008; 117(11): 1397 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bigal, A. Tsang, E. Loder, D. Serrano, M. L. Reed, R. B. Lipton, and for the American Migraine Prevalence and Preventio Body Mass Index and Episodic Headaches: A Population-Based Study Arch Intern Med, October 8, 2007; 167(18): 1964 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Jelinski, J. E. Magnusson, W. J. Becker, and for the CHORD Study Group Factors associated with depression in patients referred to headache specialists Neurology, February 13, 2007; 68(7): 489 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lipton, M. E. Bigal, M. Diamond, F. Freitag, M. L. Reed, W. F. Stewart, and on behalf of the AMPP Advisory Group Migraine prevalence, disease burden, and the need for preventive therapy Neurology, January 30, 2007; 68(5): 343 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mitrirattanakul and R. L. Merrill Headache impact in patients with orofacial pain. J Am Dent Assoc, September 1, 2006; 137(9): 1267 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Hershey and P. K. Winner Pediatric Migraine: Recognition and Treatment J Am Osteopath Assoc, April 1, 2005; 105(4_suppl): 2S - 8S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Azarbal, J. Tobis, W. Suh, V. Chan, C. Dao, and R. Gaster Association of interatrial shunts and migraine headaches: Impact of transcatheter closure J. Am. Coll. Cardiol., February 15, 2005; 45(4): 489 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.B. Lipton, D. Dodick, R. Sadovsky, K. Kolodner, J. Endicott, J. Hettiarachchi, and W. Harrison A self-administered screener for migraine in primary care: The ID MigraineTM validation study Neurology, August 12, 2003; 61(3): 375 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lipton, W. F. Stewart, and P. J. Goadsby Headache-related disability in the management of migraine Neurology, March 1, 2001; 56(suppl_1): S1 - S3. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |